INMUNE BIO INC. Sale of Stock, Price Per Share
INMUNE BIO INC. (INMB) had Sale of Stock, Price Per Share of $8.37 per share as of 2025-03-31, per its 10-Q filed 2025-05-08.
Financial Statements › Notes › Equity
us-gaap:SaleOfStockPricePerShare · last filed 2025-05-08
- 2025-03-31: Sale of Stock, Price Per Share $8.37.
- 2023-07-31: Sale of Stock, Price Per Share $10.56.
- 2020-07-31: Sale of Stock, Price Per Share $10.00.
| Period end | Sale of Stock, Price Per Share |
|---|---|
| 2025-03-31 | $8.37 10-Q · filed 2025-05-08 |
| 2023-07-31 | $10.56 10-Q · filed 2024-10-31 |
| 2020-07-31 | $10.00 10-Q · filed 2021-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |